מן הרשת 11.06.202315:00 Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer A Randomized Clinical Trial Jama Network
מן הרשת 23.05.202311:36 Severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti-PD(L)1 and sotorasib therapy in KRASG12C-mutant lung cancer Journal of Thoracic Oncology
מן הרשת 22.03.202315:38 Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study International Journal of Radiation Oncology*Biology*Physics
מן הרשת 22.03.202315:35 Poziotinib in Treatment-Naïve Non-Small-Cell Lung Cancer Poziotinib in Treatment-Naïve Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-label Phase 2 Trial (Cohort 4) Journal of Thoracic Oncology
מן הרשת 22.03.202315:34 Driver mutation characteristics of PIK3CA in advanced NSCLC Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer Lung Cancer
מן הרשת 06.03.202313:25 Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer JTO
מן הרשת 01.02.202311:00 Findings From the PACIFIC-R Study Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy Journal of Thoracic Oncology
מן הרשת 29.01.202311:12 Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21) Journal of Thoracic Oncology
מן הרשת 19.01.202311:22 Non-oncogene addicted metastatic non-small-cell lung cancer ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Annals of Oncology
מן הרשת 18.01.202311:44 Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC Patient-reported smoking history is frequently used as a stratification factor in NSCLC-directed clinical research Journal of Thoracic Oncology
מן הרשת 18.01.202311:43 clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion RET-MAP: An international multi-center study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion Journal of Thoracic Oncology
מן הרשת 18.01.202311:42 Central nervous system disease in patients with RET Original article: Central nervous system disease in patients with RET fusion-positive non-small cell lung cancer treated with selpercatinib Journal of Thoracic Oncology
מן הרשת 18.01.202311:39 Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21) Journal of Thoracic Oncology
מן הרשת 18.01.202311:37 A Clinician’s Guide to Bioinformatics for Next-Generation Sequencing Next-generation sequencing (NGS) technologies are high-throughput methods for DNA sequencing and have become a widely adopted tool in cancer research Journal of Thoracic Oncology
מן הרשת 18.01.202311:36 Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2) JTO